SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOVOLENTA, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.661
AS - Asia 2.417
EU - Europa 2.196
SA - Sud America 430
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 10.770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.540
SG - Singapore 1.055
CN - Cina 686
PL - Polonia 586
IT - Italia 392
BR - Brasile 377
DE - Germania 359
HK - Hong Kong 206
UA - Ucraina 185
GB - Regno Unito 174
TR - Turchia 152
SE - Svezia 115
VN - Vietnam 112
FI - Finlandia 105
RU - Federazione Russa 76
CA - Canada 67
ID - Indonesia 57
MX - Messico 45
BE - Belgio 42
FR - Francia 42
IN - India 40
AR - Argentina 29
NL - Olanda 29
ZA - Sudafrica 28
JP - Giappone 23
ES - Italia 22
BD - Bangladesh 21
IQ - Iraq 13
IE - Irlanda 12
AT - Austria 11
CZ - Repubblica Ceca 9
LT - Lituania 8
MA - Marocco 8
KE - Kenya 7
UZ - Uzbekistan 7
EG - Egitto 6
CO - Colombia 5
EU - Europa 5
HR - Croazia 5
PK - Pakistan 5
SA - Arabia Saudita 5
CH - Svizzera 4
CL - Cile 4
EC - Ecuador 4
KG - Kirghizistan 4
LB - Libano 4
RO - Romania 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BY - Bielorussia 3
DZ - Algeria 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AU - Australia 2
CR - Costa Rica 2
IL - Israele 2
IR - Iran 2
KR - Corea 2
LV - Lettonia 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
RS - Serbia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BO - Bolivia 1
DK - Danimarca 1
GD - Grenada 1
GL - Groenlandia 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ME - Montenegro 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 10.770
Salva come PNG Salva come JPEG
Città #
Warsaw 583
Singapore 565
Ashburn 559
Woodbridge 555
Fairfield 515
Ann Arbor 386
Houston 332
Chandler 322
Beijing 240
Santa Clara 235
Jacksonville 218
Seattle 217
Hong Kong 204
Wilmington 201
Cambridge 174
Ferrara 130
Dallas 128
Munich 124
New York 109
Los Angeles 107
Izmir 96
Nanjing 83
Milan 67
Princeton 60
Shanghai 50
Boardman 48
San Diego 48
Jakarta 45
Turku 39
Ho Chi Minh City 38
Bremen 37
Brussels 37
London 37
São Paulo 34
Mexico City 33
Dearborn 30
Chicago 28
Falls Church 23
Nanchang 23
Toronto 23
Tianjin 22
Tokyo 22
Buffalo 21
Helsinki 21
Johannesburg 21
The Dalles 21
Shenyang 20
Bologna 19
Brooklyn 18
Hanoi 18
Nuremberg 18
Hefei 17
Orem 17
Kunming 16
Rio de Janeiro 16
Atlanta 15
Denver 15
Moscow 15
Changsha 14
Phoenix 14
Poplar 14
Chennai 13
Des Moines 13
Hebei 13
Montreal 13
Dong Ket 12
Frankfurt am Main 12
Redwood City 12
Belo Horizonte 11
Brasília 11
Curitiba 11
Ottawa 11
Stockholm 11
Auburn Hills 10
Boston 10
Columbus 10
Council Bluffs 10
Falkenstein 10
Jinan 10
San Mateo 10
Washington 10
Hangzhou 9
Rome 9
Brno 8
Mountain View 8
Amsterdam 7
Ankara 7
Dublin 7
Nairobi 7
Norwalk 7
Parma 7
Vancouver 7
Zhengzhou 7
Absecon 6
Addison 6
Baghdad 6
Dhaka 6
New Delhi 6
Porto Alegre 6
Querétaro 6
Totale 7.512
Salva come PNG Salva come JPEG
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 419
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 378
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 375
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 286
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 248
Crispr/Cas9-based COL7A1 editing for recessive dystrophic epidermolysis bullosa 245
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 242
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 240
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 240
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 235
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 231
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 226
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy 224
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 221
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 220
Exon skipping-mediated dystrophin reading frame restoration for small mutations 209
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 208
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 202
Autosomal recessive Bethlem myopathy 198
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 198
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 191
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 184
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 181
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 180
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 179
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 179
Transcriptional behavior of DMD gene duplications in DMD/BMD males 174
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 167
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 167
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 163
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 162
D.P.12 Whole exome sequencing and RNAseq in a Duchenne-like female with no dystrophin mutations: Search for dystrophin gene modifiers 160
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 158
null 155
D.P.9 Whole exome sequencing filtered by novel candidate genes as tool for gene discovery in a recessive family with Parkinson and ataxia 153
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 151
G.P.15 Whole transcriptome expression profiling in COL6a1 null mice shows deregulation of circadian clock genes as exploratory COL6 myopathies biomarkers 143
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 142
D.P.7 Whole exome sequencing as genetic diagnostic tool in myofibrillar myopathies 141
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 140
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 136
null 131
Autosomal recessive Bethlem myopathy 122
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 120
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 116
Studio di CNVs nel locus HLA (6p21.32) mediante Array CGH in pazienti con Sclerosi Multipla e malformazioni venose 113
null 113
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair 110
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 109
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 108
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 106
Exploiting The CRISPR/CAS9 System to Study Alternative Splicing In Vivo: Application to titin 106
Conjugates of oligonucleotides and bile acids and their derivatives for pharmaceutical active molecules delivery 101
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 101
Transcriptional enhancement as therapeutic approach of coagulation factor VII promoter mutations 100
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 99
MOLECULAR MECHANISMS AND THERAPEUTIC APROACHES FOR RESTORATION OF mRNA TRANSCRIPTION, MATURATION AND TRANSLATION IN INHERITED COAGULATION FACTOR DEFICIENCIES 99
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 93
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 87
A new rat model for Duchenne muscular dystrophy generated by CRISPR-induced deletion of Exon 45 87
null 86
Synthesis and exon‐skipping properties of a 3′‐ursodeoxycholic acid‐conjugated oligonucleotide targeting dmd pre‐mrna: Pre‐synthetic versus post‐ synthetic approach 85
Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system 83
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 82
Efficient generation of mouse models with the CRISPR/Cas9 technology 77
Targeted Genome Editing in Spinal Muscular Atrophy 43
Totale 10.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 0 75 90 99 52 139 121 56
2021/2022746 41 55 47 37 33 35 67 38 31 62 86 214
2022/2023812 75 82 8 111 154 93 52 63 85 11 44 34
2023/2024435 35 47 37 10 35 97 10 30 10 5 12 107
2024/20251.968 41 30 158 119 254 149 88 98 400 158 274 199
2025/20262.488 514 156 409 581 768 60 0 0 0 0 0 0
Totale 10.928